Vir Biotechnology, Inc.
VIR · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $698 | $891 | $1,004 |
| - Cash | $170 | $299 | $274 | $223 |
| + Debt | $91 | $93 | $96 | $98 |
| Enterprise Value | – | $492 | $713 | $879 |
| Revenue | $0 | $1 | $3 | $12 |
| % Growth | -80.2% | -60% | -75.5% | – |
| Gross Profit | -$151 | -$96 | -$115 | -$76 |
| % Margin | -63,005% | -7,932.9% | -3,779.1% | -617.5% |
| EBITDA | -$160 | -$116 | -$136 | -$100 |
| % Margin | -66,656.3% | -9,528.2% | -4,474.3% | -810% |
| Net Income | -$163 | -$111 | -$121 | -$105 |
| % Margin | -67,975.4% | -9,139.9% | -3,989.6% | -845.2% |
| EPS Diluted | -1.17 | -0.8 | -0.88 | -0.76 |
| % Growth | -46.2% | 9.1% | -15.8% | – |
| Operating Cash Flow | -$168 | -$120 | -$78 | -$88 |
| Capital Expenditures | -$0 | -$3 | -$2 | -$2 |
| Free Cash Flow | -$168 | -$123 | -$80 | -$90 |